A detailed history of King Luther Capital Management Corp transactions in Pfizer Inc stock. As of the latest transaction made, King Luther Capital Management Corp holds 2,501,015 shares of PFE stock, worth $66.9 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
2,501,015
Previous 2,357,182 6.1%
Holding current value
$66.9 Million
Previous $66 Million 9.74%
% of portfolio
0.31%
Previous 0.3%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $3.98 Million - $4.51 Million
143,833 Added 6.1%
2,501,015 $72.4 Million
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $5.25 Million - $6.15 Million
207,837 Added 9.67%
2,357,182 $66 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $3.58 Million - $4.11 Million
138,329 Added 6.88%
2,149,345 $59.6 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $309,980 - $402,630
11,863 Added 0.59%
2,011,016 $57.9 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $2.51 Million - $2.93 Million
-78,140 Reduced 3.76%
1,999,153 $66.3 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $3.89 Million - $4.5 Million
-107,595 Reduced 4.92%
2,077,293 $76.2 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $3.63 Million - $4.73 Million
-92,248 Reduced 4.05%
2,184,888 $89.1 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $109,259 - $142,626
-2,617 Reduced 0.11%
2,277,136 $117 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $168,300 - $205,453
-3,846 Reduced 0.17%
2,279,753 $99.8 Million
Q2 2022

Aug 11, 2022

SELL
$46.53 - $55.17 $316,171 - $374,880
-6,795 Reduced 0.3%
2,283,599 $120 Million
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $473,009 - $586,117
10,339 Added 0.45%
2,290,394 $119 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $936,476 - $1.39 Million
22,664 Added 1.0%
2,280,055 $135 Million
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $5.26 Million - $6.75 Million
-133,942 Reduced 5.6%
2,257,391 $97.1 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $1.98 Million - $2.24 Million
-55,044 Reduced 2.25%
2,391,333 $93.6 Million
Q1 2021

May 12, 2021

SELL
$33.49 - $37.77 $2.03 Million - $2.29 Million
-60,669 Reduced 2.42%
2,446,377 $88.6 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $2.06 Million - $2.62 Million
-61,453 Reduced 2.39%
2,507,046 $92.3 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $601,472 - $705,664
18,944 Added 0.74%
2,568,499 $94.3 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $13.2 Million - $16 Million
-438,255 Reduced 14.67%
2,549,555 $83.4 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $2.22 Million - $3.17 Million
82,073 Added 2.82%
2,987,810 $97.5 Million
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $48,161 - $54,657
-1,463 Reduced 0.05%
2,905,737 $114 Million
Q3 2019

Nov 12, 2019

BUY
$32.49 - $42.13 $158,161 - $205,088
4,868 Added 0.17%
2,907,200 $104 Million
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $912,703 - $1.02 Million
-24,681 Reduced 0.84%
2,902,332 $126 Million
Q1 2019

May 10, 2019

SELL
$37.5 - $41.2 $1.33 Million - $1.47 Million
-35,596 Reduced 1.2%
2,927,013 $124 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $600,785 - $684,961
-15,617 Reduced 0.52%
2,962,609 $129 Million
Q3 2018

Nov 13, 2018

SELL
$34.47 - $41.81 $3.19 Million - $3.86 Million
-92,412 Reduced 3.01%
2,978,226 $131 Million
Q2 2018

Aug 13, 2018

SELL
$32.98 - $35.16 $4.93 Million - $5.25 Million
-149,458 Reduced 4.64%
3,070,638 $111 Million
Q1 2018

May 08, 2018

SELL
$31.91 - $37.02 $11,774 - $13,660
-369 Reduced 0.01%
3,220,096 $114 Million
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $14.4 Million - $15.3 Million
432,474 Added 15.51%
3,220,465 $117 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $86.4 Million - $95.2 Million
2,787,991
2,787,991 $99.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.